Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T State of the Art and Future Challenges, A Regulatory Perspective
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11803-11803
Open Access | Times Cited: 19

Showing 19 citing articles:

The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
Margherita Passariello, Lorenzo Manna, Rosa Rapuano Lembo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
Alexandra Dreyzin, Alexander W. Rankin, Katia Luciani, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 745-763
Closed Access | Times Cited: 6
Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation
Maria Elisabeth Kalland, Tomás Pose‐Boirazian, Gloria M. Palomo, et al.
Gene Therapy (2024) Vol. 31, Iss. 7-8, pp. 366-377
Open Access | Times Cited: 5
Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations
Katie S. Gatwood, Zahra Mahmoudjafari, Brittney Baer, et al.
Clinical Hematology International (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 4
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
Eleonora Pinto, Lisa A. Lione, Mirco Compagnone, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Establishing a GMP-compliant manufacturing process and phase-appropriate analytics for early development of a FiCAR T-cell product with a novel CAR spacer
Annu Luostarinen, Arto Vuorela, Erja Kerkelä, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Preparing for the future of precision medicine: synthetic cell drug regulation
Kira Sampson, Carlise Sorenson, Katarzyna P. Adamala
Synthetic Biology (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Developing CAR-immune cell therapy against SARS-CoV-2: Current status, challenges and prospects
Yizhao Chen, Chong Liu, Yilong Fang, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116066-116066
Closed Access | Times Cited: 3
Revolutionizing CAR T Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and Accessibility
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
(2024)
Open Access | Times Cited: 2
Revolutionizing CAR T-Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and Accessibility
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10365-10365
Open Access | Times Cited: 2
Advancement in “Off-the-Shelf” CAR T-Cell Therapy for Cancer Immunotherapy
Mohsen Sheykhhassan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 33-92
Closed Access | Times Cited: 1
Modern immunotherapy using CAR-T cells in haemato-oncology and solid tumors
Anna Bogacz, Alicja Bukowska, Marta Bukowska, et al.
Acta Haematologica Polonica (2024)
Open Access
Targeting Tumors
Safiya Mehraj, Shazia Ali
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 93-122
Closed Access
The 5T's of health disparities in multiple myeloma in Latin America
Humberto Martínez‐Cordero, Cynthia Fuentes-Lacouture, Alana Von Glasenapp, et al.
Current Opinion in Oncology (2024)
Closed Access
Molecular profiling and therapeutic tailoring to address disease heterogeneity in systemic lupus erythematosus
Abhibroto Karmakar, Uma Kumar, Smitha Prabhu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
Regina Mirgayazova, Raniya Khadiullina, Maria Filimonova, et al.
Exploration of Immunology (2024), pp. 837-852
Open Access
Recent Advancement in Car-T-Cell Therapy
Vivek Pazhamalai, G. Manideepa, R. Mathumida
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 237-264
Closed Access
Adoptive cell therapy for treatment of rare diseases and orphan designation.
Maria Elisabeth Kalland, Tomas Pose, Gloria M. Palomo, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top